| Name |
NMN |
| Synonyms |
β-Nicotinamide mononucleotide |
| CAS |
1094-61-7 |
| EINECS |
214-136-5 |
| Formula |
C11H16N2O8P |
| Molar Mass |
334.22 |
| Density |
|
| Melting Point |
166 °C(dec.) |
| Boiling Point |
|
| Flash Point |
|
| Water Solubility |
DMSO (Slightly, Heated), Methanol (Slightly), Water (Slightly) |
| Vapor Pressure |
|
| Refractive Index |
|
| Specific Rotation |
|
| Use |
After NMN administration, there was no difference in blood glucose levels in i.p. GTTs between Nampt+/- and control female mice. In addition, NMN-treated Nampt+/- and control mice also had similar plasma insulin levels at each time point. These data clearly indicate that NMN administration corrects the defect in GSIS observed in Nampt+/- mice.
|
| Physical and Chemical Properties |
White powder |
| Safety Description |
|
| Risk Codes |
|
| Hazard Symbols |
|
